rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

June Lee

Director

Company insider

Files Form 4 as: Director, Tenaya Therapeutics; Director, Eledon Pharmaceuticals; Director, CinCor Pharma; EVP, Chief Development Officer, MyoKardia.

Every Form 4 they filed

In numbers

Trades disclosed
76
Buys
0
Sells
5
Bought
$0
Sold
$2.0M
Companies
4
Companies where not an officer
3
First trade
1 Feb 2017
Last trade
28 May 2026
Last filed
29 May 2026

Companies traded

Where they are an officer
MyoKardiaOfficer · last 23 Sep 20190 buys · 5 sells
Everywhere else they filed: board seats, 10% stakes, other companies
TNYA Tenaya TherapeuticsDirector · Biotechnology · last 28 May 20260 buys · 0 sells
ELDN Eledon PharmaceuticalsDirector · Biotechnology · last 10 Jan 20260 buys · 0 sells
CinCor PharmaDirector · last 24 Feb 20230 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
28 May 2026filed 29 May 2026TNYA Tenaya Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—120,000 at $0.00filing
28 May 2026filed 29 May 2026TNYA Tenaya Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—120,000 at $0.00filing
10 Jan 2026filed 16 Jan 2026ELDN Eledon PharmaceuticalsBiotechnologySEC FORM 4 Code M—3,430 at $0.00filing
10 Jan 2026filed 16 Jan 2026ELDN Eledon Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—3,430 at $0.00filing
10 Jan 2026filed 16 Jan 2026ELDN Eledon Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—3,430 at $0.00filing
10 Jan 2026filed 16 Jan 2026ELDN Eledon PharmaceuticalsBiotechnologySEC FORM 4 Code M—3,430 at $0.00filing
29 May 2025filed 30 May 2025TNYA Tenaya Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—107,400 at $0.00filing
10 Jan 2025filed 13 Jan 2025ELDN Eledon Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—30,870 at $0.00filing
10 Jan 2025filed 13 Jan 2025ELDN Eledon Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—3,430 at $0.00filing
18 Oct 2024filed 21 Oct 2024TNYA Tenaya Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—34,000 at $0.00filing
9 Jun 2023filed 12 Jun 2023TNYA Tenaya Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—29,532 at $0.00filing
1 May 2023filed 2 May 2023ELDN Eledon Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—150,437 at $0.00filing
24 Feb 2023filed 24 Feb 2023CinCor Pharmaoption or derivativeSEC FORM 4 Code D—47,954filing
1 Feb 2023filed 2 Feb 2023ELDN Eledon Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
10 Jun 2022filed 13 Jun 2022TNYA Tenaya Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—39,727 at $0.00filing
1 Feb 2022filed 2 Feb 2022ELDN Eledon Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
6 Jan 2022filed 10 Jan 2022CinCor Pharmaoption or derivativeSEC FORM 4 Code A—47,954 at $0.00filing
19 Nov 2021filed 22 Nov 2021TNYA Tenaya Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—18,937 at $0.00filing
23 Sep 2019filed 24 Sep 2019MyoKardiaoption or derivativeSEC FORM 4 Code M—12,625 at $0.00filing
23 Sep 2019filed 24 Sep 2019MyoKardiaSEC FORM 4 Code M$151K12,625 at $11.95filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed5

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.